ITEMS IN AFP WITH KEYWORD:

Asthma

Nov 01, 2021 Issue
Asthma Management: Updated Guidelines from the National Heart, Lung, and Blood Institute [Practice Guidelines]

The National Heart, Lung, and Blood Institute (NHLBI) published asthma management guidelines in 1991 and 2007. In 2020, the NHLBI released an update focusing on six priority topics.


Nov 01, 2021 Issue
Asthma Management Guidelines: Focused Updates for 2020 [Editorials]

The 2020 Focused Updates to the asthma management guidelines represent the first revision of the National Asthma Education and Prevention Program guidelines in more than 10 years. The report differs from the Global Initiative for Asthma recommendations because of the focused number of issues addressed and the nature of the evidence review.


Mar 1, 2021 Issue
Difficult-to-Treat and Severe Asthma: Management Strategies [Article]

Management of difficult-to-treat asthma includes confirming the diagnosis of asthma, addressing contributing factors, and optimizing treatment. An adequate trial of an inhaled corticosteroid and long-acting beta agonist should be implemented with nonbiologic add-on therapies. Nonpharmacologic therapies should also be considered. Management of severe asthma includes assessment of asthma phenotype to determine which patients may benefit from biologic therapy.


Feb 15, 2021 Issue
Intravenous Magnesium Sulfate for Acute Asthma Exacerbation in Children and Adults [Medicine by the Numbers]

Patients who received intravenous magnesium sulfate for acute asthma exacerbation in the emergency department had decreased hospital admissions and no serious adverse effects.


Oct 15, 2020 Issue
School-Based Asthma Management Programs [FPIN's Help Desk Answers]

Comprehensive public school–based programs providing supervised administration of asthma medication and/or education for staff, children, and parents markedly decrease asthma-related ED visits for school-aged children.


Oct 1, 2020 Issue
Effects of Inhaled Corticosteroids on Growth in Children with Persistent Asthma [Cochrane for Clinicians]

Inhaled fluticasone (Flovent; 200 mcg per day) is associated with a greater linear growth velocity when compared with beclomethasone (400 mcg per day; an equivalent dose).


Jun 15, 2020 Issue
Asthma: Updated Diagnosis and Management Recommendations from GINA [Practice Guidelines]

The latest update to the Global Initiative for Asthma (GINA) guidelines includes significant changes to treatment recommendations, especially a recommendation against using a short-acting beta2 agonists such as albuterol as sole therapy.


Mar 15, 2020 Issue
Office Spirometry: Indications and Interpretation [Article]

High-quality, office-based spirometry can be as useful and reliable as testing performed in a pulmonary function laboratory. A stepwise approach to spirometry should be used, including assessing for obstruction and reversibility, grading of severity, and referral for full pulmonary testing as indicated.


Mar 1, 2020 Issue
Fewer Severe Exacerbations in Patients with Mild to Moderate Asthma Treated with As-Needed Budesonide Plus Formoterol Compared with Maintenance Budesonide [POEMs]

Patients with mild to moderate asthma only need relief treatment. In this study, patients taking the combination of budesonide/formoterol (Symbicort) as needed had slightly fewer severe exacerbations than patients treated with twice daily budesonide (Pulmicort).


Feb 15, 2020 Issue
Dupilumab (Dupixent) for Asthma [STEPS]

Dupilumab is an effective injectable drug that decreases asthma exacerbations and the need for an oral glucocorticoid in patients with moderate to severe asthma, particularly those with high eosinophil counts.


Pages: 1 2 3 4 5 6 7 8 Next


Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now